Science Explorer Back to mapMap
Discussion
Researcher · Mapi Pharma (Israel) · Israel

Ehud Marom

Ehud Marom publishes mostly in Pathology and Forensic Medicine, Oncology and Molecular Biology, on topics such as Multiple Sclerosis Research Studies, Advanced Drug Delivery Systems and Peptidase Inhibition and Analysis.

OpenAlex
World rank
#7,161,267
of 7,710,434 ranked researchers
Rank in Israel
#37,270
of 38,292
Works
23
Citations
32
Citations per work
1.4
h-index
3
i10-index 1Top 96% in Pathology and Forensic Medicine
Ehud Marom

What does Ehud Marom research?

Ehud Marom's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (10%), Pharmacology, Toxicology and Pharmaceutics (6%).

Health Sciences: 10 works · 44.9% of their workMedicine: 10 works · 44.9% of their workPathology and Forensic Medicine: 6 works · 24.5% of their workOncology: 2 works · 10.2% of their workGenetics: 1 works · 6.1% of their workEndocrinology, Diabetes and Metabolism: 1 works · 4.1% of their workEverything else: 9 works · 38.8% of their workLife Sciences: 4 works · 16.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.2% of their workMolecular Biology: 2 works · 10.2% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 6.1% of their workPharmaceutical Science: 1 works · 6.1% of their workTHEIR WORKEhud Marom23works
Life Sciences16%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1044.9%
  2. Everything else938.8%
    1. Biochemistry, Genetics and Molecular Biology210.2%
    2. Pharmacology, Toxicology and Pharmaceutics16.1%
  1. 1Pathology and Forensic Medicine24% of their works
  2. 2Oncology10% of their works
  3. 3Molecular Biology10% of their works
  4. 4Genetics6% of their works
  5. 5Pharmaceutical Science6% of their works
  6. 6Endocrinology, Diabetes and Metabolism4% of their works

Research topics

Which keywords describe Ehud Marom's research?

The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Angiogenesis, Stromal Cells, Extracellular Matrix, Chitosan, Fibroblast Activation Protein and Nanoparticles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Diagnostic Criteria111 topic
  2. Multiple Sclerosis111 topic
  3. Angiogenesis73 topics
  4. Stromal Cells52 topics
  5. Extracellular Matrix42 topics
  6. Chitosan31 topic
  7. Fibroblast Activation Protein31 topic
  8. Nanoparticles31 topic
  9. Tumor Microenvironment31 topic
  10. Adult Stem Cells21 topic
  11. Cardiovascular Outcomes21 topic
  12. Cell Adhesion21 topic
  13. Integrins21 topic
  14. Matrix Metalloproteinases21 topic
  15. Mesenchymal Stem Cells21 topic
  16. Multipotent21 topic
  17. Neurogenesis21 topic
  18. Tissue Inhibitors of Metalloproteinases21 topic
  19. Type 2 Diabetes21 topic

Where does Ehud Marom work?

Ehud Marom's main affiliation in the publication record is Mapi Pharma (Israel), Israel.

How many publications and citations does Ehud Marom have?

OpenAlex counts 23 works and 32 citations for Ehud Marom, an h-index of 3, ranking #7,161,267 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ehud Marom. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.